SETD2 and nonpapillary renal cell carcinoma: The SETD2 gene, inactivated in 8%–30% of ccRCC cases, alters the transcription, DNA damage repair, and selective splicing through its regulation of H3K36 trimethylation (H3K36me3) (Mano et al., 2021; Walton et al., 2023).